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Abstract
Phosphorylation of tyrosine residues on platelet–endothelial cell adhesion molecule-1 (PECAM-1), followed
by signal trans- 13 duction events, has been described in endothelial cells following exposure to hyperosmotic
and fluid shear stress. However, it is 14 unclear whether PECAM-1 functions as a primary mechanosensor in
this process. Utilizing a PECAM-1–null EC-like cell line, we 15 examined the importance of cellular
localization and the extracellular and transmembrane domains in PECAM-1 phosphorylation 16 responses to
mechanical stress. Tyrosine phosphorylation of PECAM-1 was stimulated in response to mechanical stress in
null cells 17 transfected either with full length PECAM-1 or with PECAM-1 mutants that do not localize to
the lateral cell–cell adhesion site and 18 that do not support homophilic binding between PECAM-1
molecules. Furthermore, null cells transfected with a construct that 19 contains the intact cytoplasmic domain
of PECAM-1 fused to the extracellular and transmembrane domains of the interleukin-2 20 receptor also
underwent mechanical stress-induced PECAM-1 tyrosine phosphorylation. These findings suggest that
mechano- 21 sensitive PECAM-1 may lie downstream of a primary mechanosensor that activates a tyrosine
kinase.
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11 Abstract
12 Phosphorylation of tyrosine residues on platelet–endothelial cell adhesion molecule-1 (PECAM-1), followed by signal trans-
13 duction events, has been described in endothelial cells following exposure to hyperosmotic and ﬂuid shear stress. However, it is
14 unclear whether PECAM-1 functions as a primary mechanosensor in this process. Utilizing a PECAM-1–null EC-like cell line, we
15 examined the importance of cellular localization and the extracellular and transmembrane domains in PECAM-1 phosphorylation
16 responses to mechanical stress. Tyrosine phosphorylation of PECAM-1 was stimulated in response to mechanical stress in null cells
17 transfected either with full length PECAM-1 or with PECAM-1 mutants that do not localize to the lateral cell–cell adhesion site and
18 that do not support homophilic binding between PECAM-1 molecules. Furthermore, null cells transfected with a construct that
19 contains the intact cytoplasmic domain of PECAM-1 fused to the extracellular and transmembrane domains of the interleukin-2
20 receptor also underwent mechanical stress-induced PECAM-1 tyrosine phosphorylation. These ﬁndings suggest that mechano-
21 sensitive PECAM-1 may lie downstream of a primary mechanosensor that activates a tyrosine kinase.
22  2004 Published by Elsevier Inc.
23 Keywords: Platelet endothelial adhesion molecule-1; Endothelial mechanotransduction; Hyperosmotic stress; Fluid shear stress
24 Mechanical stresses, including ﬂuid shear stress (FSS),
25 play an important role in determining endothelial cell
26 (EC) behavior, modulating their physiology, gene ex-
27 pression, and morphology [1,2]. Transfer of FSS forces
28 to the EC ﬁrst occurs at the luminal cell surface where
29 molecules whose conformations are directly aﬀected by
30 FSS may act as mechanosensors or mechanotransducers.
31 In addition, sites remote from the initial stimulus may act
32 as mechanosensors or mechanotransducers as the force
33 of FSS is transmitted throughout the cell via the cyto-
34skeleton [1]. One such location is the lateral cell–cell
35adhesion site [3].
36Recently, investigators have identiﬁed a possible
37role for platelet–endothelial cell adhesion molecule-1
38(PECAM-1, CD31) in the sensation of hyperosmotic
39stress (HOS) and FSS and subsequent signal trans-
40duction events [4–6]. PECAM-1 is a 130-kDa mem-
41ber of the immunoglobulin superfamily that is
42expressed abundantly on the cell surface of ECs,
43platelets, and many leukocytes. A striking feature of
44PECAM-1 is its localization at the cell–cell border
45between adjacent endothelial cells [7,8]. This speciﬁc
46localization may be important to the vascular function
47of PECAM-1, playing a role in leukocyte transmigra-
48tion of EC monolayers [9]. In conﬂuent endothelial
49cells, PECAM-1 molecules on adjacent cells bind
50homophilically to each other via extracellular domains
511 and 2 [10].
qAbbreviation: PECAM-1, platelet–endothelial cell adhesion mol-
ecule-1.
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52 REN cells are endothelial-like cells derived from
53 human malignant mesothelioma [11]. In culture, they
54 form a conﬂuent monolayer and adopt a “cobblestone”
55 morphology reminiscent of ECs (Fig. 1). In addition,
56 REN cells express several surface antigens in common
57 with ECs but lack PECAM-1; they can be transfected
58 stably with wild-type or mutant forms of PECAM-1
59 (Fig. 2A). We have previously used REN cells as an
60 EC model, ﬁnding that many EC signaling processes
61 may be reconstituted after PECAM-1 expression
62 [12,13].
63 Utilizing this null cell, we reasoned that if PECAM-1
64 is a mechanosensor, force-induced PECAM-1 phos-
65 phorylation may require localization to, and organiza-
66 tion at, the lateral cell–cell border. We also explored
67 whether the cytoplasmic, extracellular or transmembrane
68 domains of PECAM-1 are necessary for PECAM-1
69 mechanosignaling.
70Materials and methods
71Antibodies, reagents, immunoprecipitation, and Western blotting.
72Antibodies included the following: mAb 4G6, a murine immuno-
73globulin (IgG) directed against the PECAM-1 extracellular Ig loop six
74domain [14]; mAb 1.3, a murine IgG directed against the PECAM-1
75extracellular domain (a gift of Dr. Peter Newman, Blood Center of
76Southeastern Wisconsin, Milwaukee, WI); PCD, a rabbit polyclonal
77antibody directed against the PECAM-1 cytoplasmic domain; ab8325
78(Abcam, Cambridge, UK), a murine mAb directed against the
79a-subunit of the interleukin-2 receptor (IL2R); anti-SHP-2 mAb (Cell
80Signaling Technology, Santa Cruz, CA); and PY20 (Transduction
81Laboratories, BD Biosciences, Palo Alto, CA), an anti-phosphotyro-
82sine rabbit polyclonal Ab. Puriﬁed antibodies were obtained by protein
83G aﬃnity chromatography of hybridoma supernatants or serum.
84Active binding of antibodies was conﬁrmed by ﬂow cytometry.
85For immunoprecipitation, thawed lysates were preabsorbed with
86protein A-conjugated Sepharose beads (Amersham–Pharmacia). After
87removal from the beads, the precleared supernatants were transferred
88to fresh microfuge tubes and immunoprecipitated by incubation with
89mAb 4G6 (for WT PECAM-1 and the K151/R152A mutant) or
Fig. 2. (A) Isoforms of PECAM-1 transfected into REN cells. (B) Distribution of PECAM-1 isoforms transfected into REN cells. (Left panel) Wild-
type PECAM-1 localizes to the lateral cell–cell border. (Center panel) The K151A/R152A-PECAM mutant is found diﬀusely on the cell membrane,
as is the IL2-EDM/TM-PECAM-CD mutant (right panel).
Fig. 1. Morphology of HAEC (left) and REN cells (right) in culture. Cells were cultured on gelatin-covered glass microscope slides and grown to
conﬂuence 48 h after seeding. Photomicrographs were obtained just prior to application of shear stress in a parallel plate ﬂow chamber (described in
[18]).
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90 ab8325 (for the IL2PCD construct), followed by incubation with
91 protein A-conjugated Sepharose beads.
92 Lysates were then separated on 4–12% gradient SDS–polyacryl-
93 amide reducing gels (Invitrogen) and transferred to PVDF membranes
94 (Millipore). Membranes were probed with mAb 1.3 or pAb PCD and
95 then counterstained with HRP-conjugated donkey anti-mouse IgG
96 (Cappel) or HRP-conjugated goat-anti-rabbit IgG (Jackson), and
97 signals were visualized with ECL (Amersham–Pharmacia). Mem-
98 branes were then stripped in a buﬀer containing 62.5mM Tris–HCl
99 (pH 6.8), 2% SDS, and 100mM of 2-mercaptoethanol, then reprobed
100 with PY20 and counterstained with HRP-conjugated goat-anti-rabbit
101 IgG. Signals were again detected by ECL. Images were captured on a
102 desktop scanner (Canon CanoScan D1250U2F) utilizing Adobe
103 Photoshop 7.0.
104 Cell lines and mutant PECAM-1 constructs. Human aortic endo-
105 thelial cells (HAEC, Clonetics) were cultured in endothelial basic
106 medium-2 (EBM-2, Clonetics) containing 2% fetal bovine serum and
107 Bullet kit reagents (Clonetics). Only HAECs between passages 2 and 6
108 were used.
109 REN cells, a human mesothelioma cell line previously isolated in
110 our laboratories [11], were grown in RPMI (Gibco) supplemented with
111 10% FBS and 2mM L-glutamine (R10 media) containing 10,000U
112 penicillin and 10,000U streptomycin. PECAM-1 mutant constructs
113 IL2PCD and K151/R152A [15] as well as wild-type PECAM-1 were
114 subcloned into the pcDNA-neo vector and transfected into REN cells.
115 Expression was subsequently conﬁrmed by ﬂow cytometry (Coulter) as
116 described previously [12]. Stable polyclonal populations of REN cell
117 transfectants were generated by bead sorting (Dynal) and selected in
118 G418 (0.5mg/mL) supplemented R10 media as previously described
119 [13].
120 The IL2PCD PECAM-1 mutant contains the extracellular and
121 cytoplasmic domains of the interleukin-2 receptor fused to the full
122 cytoplasmic domain of PECAM-1 [15]. The K151/R152A mutant
123 contains mutations lysine–arginine (KR) at amino acid positions 151
124 and 152 to alanine–alanine in the putative glycosaminoglycan binding
125 region of PECAM-1 (amino acids 149–155, see [16]). Previously, these
126 mutant forms of PECAM-1 have been demonstrated to spread dif-
127 fusely over the cell surface rather than localize to lateral cell–cell ad-
128 hesion junctions, and we conﬁrmed these observations in the cell lines
129 used for these experiments (Fig. 2B) [15].
130 Immunoﬂuorescent staining. Cells were grown on gelatin-coated
131 coverslips, washed in phosphate-buﬀered saline (PBS), ﬁxed with 3%
132 paraformaldehyde for 20min, and then permeabilized with ice-cold
133 0.5% NP-40 for 1min. After washing, cells were stained using anti-
134 PECAM-1 mAb 4G6 and polyclonal antibody “PCD” (directed
135 against the cytoplasmic domain of PECAM-1) as previously described
136 [17]. Cells were viewed on a Nikon eclipse E400 ﬂuorescence micro-
137 scope using a 40 oil ﬂuorescence lens and photographed with a
138 Nikon Coolpix 4500 digital camera.
139 Hyperosmotic stress and ﬂuid shear stress. Cells were seeded onto
140 gelatin-coated glass microscope slides 48 h prior to the experiment
141 and grown to conﬂuence. For experiments with HAECs, EBM-2
142 (Clonetics) containing 2% fetal bovine serum and Bullet kit reagents
143 (Clonetics), supplemented with 1% dextran, was used. To enhance the
144 PY-PECAM-1 signal, this medium was supplemented with 5mM
145 NaVO3 (pH 7.4); HAECs incubated for 3 h in NaVO3-containing
146 medium were used as a positive PY-PECAM-1 control.
147 REN cells were incubated in R10 medium containing 1% dextran
148 and 5mM NaVO3 (pH 7.4) at 37 C for 2 h prior to exposure to me-
149 chanical stress. For FSS, glass slides were placed in a parallel plate ﬂow
150 chamber [18] and subjected to 13 dyn/cm2 of continuous shear stress
151 for 15min with cell growth media supplemented with 1% dextran (to
152 increase the media’s viscosity) and 5mM NaVO3. For HOS, cells were
153 exposed to medium containing 1% dextran, 5mM NaVO3, and
154 600mM sucrose. After mechanical stress, cells were washed twice with
155 ice-cold PBS containing 1mM NaVO3 and lysed for 20min on ice with
156 a buﬀer containing 0.01M Tris–acetate (pH 8.0), 0.5% NP-40, 0.5mM
157Ca2þ, 10mcg/mL leupeptin, 10mcg/mL aprotinin, 2mM PMSF, and
1582mM NaVO3. Lysates were centrifuged at 14,000g for 10min at 4 C
159and the supernatant was stored at )80 C.
160Results and discussion
161Fluid shear stress leads to tyrosine phosphorylation of
162PECAM-1 in HAECs and REN cells transfected with
163wild-type PECAM-1
164FSS and HOS induce tyrosine phosphorylation of
165PECAM-1 in cultured bovine aortic endothelial cells
166[5,6]. To conﬁrm this observation, and to ascertain
167whether this phenomenon is present in human EC,
168physiologic FSS (13 dyn/cm2) was applied for 15min, or
169HOS for 10min, to cultured HAECs. PECAM-1 puri-
170ﬁed from HAECs subjected to FSS demonstrated sig-
171niﬁcantly higher levels of tyr-P than controls (Fig. 3).
172We also conﬁrmed the observation that PECAM-1–tyr-
173P co-immunoprecipitated with SHP-2, as observed by
174other investigators (data not shown) [19].
175In order to explore the role of PECAM-1 as a
176mechanosensitive molecule in depth, we chose the REN
177cell model as a null cell. Because wild-type-PECAM-1 is
178expressed abundantly on all known lines of ECs, de-
179tecting the eﬀects of mutations to PECAM-1 is diﬃcult.
180Some investigators have employed anti-sense s-oligo
181techniques to knock down the expression of wt-PE-
182CAM-1, but such techniques only suppress the expres-
183sion of wt-PECAM-1 to approximately 70% of normal
184[5]. Thus, we subjected REN cells transfected with wt-
185PECAM-1 (REN-HP) to FSS and HOS. In order to
186strengthen the PECAM-1–tyr-P signal in Western blot-
187ting, phosphatase activity was inhibited by incubating
188the cells with growth media containing 5mMNaVO3 for
1892 h prior to FSS or HOS (control samples were incu-
190bated with growth media containing 5mM NaVO3 for
1912 h 15min). FSS or HOS stimulated tyr-P of PECAM-1
Fig. 3. Three hour incubation with 5mM sodium vanadate and
15min of ﬂuid shear stress (FSS) lead to tyrosine phosphorylation of
PECAM-1 in HAECs. Cell lysates were immunoprecipitated with
anti-PECAM-1 mAb 4G6 and membranes were blotted with anti-
PECAM-1 mAb 1.3 (upper panel). Membranes were then stripped
and reprobed with anti-PY pAb PY20 (lower panel).
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192 in REN-HP cells when compared with static control
193 (Fig. 4). In Western blotting of lysates of REN cells, a
194 negative control lacking PECAM-1, as expected, no
195 corresponding band was visible (data not shown).
196 Homophilic PECAM-1 binding is not required for
197 mechanically induced tyrosine phosphorylation
198 In a study of mechanically induced PECAM-1–tyr-P,
199 Osawa et al. [6] proposed a model in which mechanical
200 force acts directly on PECAM-1, causing a conforma-
201 tional change that permits tyr-P of the cytoplasmic do-
202 main of PECAM-1. To explore whether lateral cell–cell
203 adhesion site localization and homophilic binding be-
204 tween PECAM-1 molecules on adjacent cells are re-
205 quired for force-induced PECAM-1–tyr-P, REN cells
206 stably expressing the K151/R152A mutant form of PE-
207 CAM-1 were exposed to 15min of FSS or 10min of
208 HOS. In previous work, we noted that this mutant form
209 of PECAM-1 does not localize to the lateral cell–cell
210 border (Fig. 2) and does not support homophilic bind-
211 ing [15]. FSS and HOS stimulated increased PECAM-1–
212 tyr-P in REN cells transfected with the K151/R152A
213 mutant form of PECAM-1 (Fig. 5), demonstrating that
214 membrane localization and homophilic binding between
215 conﬂuent cells are not required for mechanosignaling
216 responses.
217The extracellular and transmembrane domains of
218PECAM-1 are not required for mechanically induced
219tyrosine phosphorylation
220To explore the importance of the extracellular and
221transmembrane domains of PECAM-1 in mechanosen-
222sation, we exposed REN cells transfected with mutant
223forms of PECAM-1 to FSS. In previous experiments, we
224have demonstrated that when a mutant form of PE-
225CAM-1 containing the non-homologous IL2R extra-
226cellular and transmembrane domains fused to the intact
227PECAM-1 cytoplasmic domain (IL2PCD mutant) is
228transfected into REN cells, it is expressed diﬀusely
229throughout the cell membrane (Fig. 2), but continues to
230serve as a substrate for c-Src-dependent, H2O2-induced
231PECAM-1–tyr-P [15,20]. In addition, this PECAM-1
232mutant regulates H2O2-induced cation channel activity
233with kinetics identical to that of wt-PECAM-1 [20].
234REN cells stably transfected with the IL2PCD mutant
235of PECAM-1 were exposed to FSS and HOS as de-
236scribed above in the presence of phosphatase inhibition
237by vanadate. Both forms of mechanical stress resulted in
238increased PECAM-1–tyr-P in REN cells transfected
239with the IL2PCD mutant form of PECAM-1 (Fig. 6).
240After conﬁrming that native PECAM-1 undergoes
241tyrosine phosphorylation in response to mechanical
242stress in human endothelial cells, we have reproduced
243the phenomenon in endothelium-like REN cells trans-
244fected with PECAM-1. Since this is a null cell, it per-
245mitted an investigation of altered protein structure and
246cellular localization in PECAM mechanosensing by
247transfection of PECAM-1 mutant constructs. Lateral
248cell–cell border localization is not required for force-
249induced PECAM-1 tyrosine phosphorylation. Osawa
250et al. [6] demonstrated a similar ﬁnding in sparsely cul-
251tured cells. Our work extends this ﬁnding to the highly
252structured conﬂuent monolayer, a situation found in
253vivo and reproduced in both endothelial and REN in
254vitro, where homophilic binding occurs between PE-
255CAM-1 molecules on adjacent cells. Not only does
256force-induced PECAM-1–tyr-P appear to be indepen-
257dent of PECAM localization to the lateral membrane,
258but it appears that neither the extracellular nor trans-
259membrane domains are necessary for mechanosignaling.
260The mutant forms of PECAM-1–tyr-P also associated
261with the phosphatase SHP-2, as shown by other inves-
262tigators [19] indicating all transfected forms of PECAM-
2631 to be a substrate for a tyrosine kinase in the present
264study. The evidence suggests that mechanosensors may
265activate a tyrosine kinase that in turn phosphorylates
266the cytoplasmic domain of PECAM-1, leading to SHP2
267activation and eventually Erk-1/2 activation. It has been
268suggested that PECAM-1 may regulate or associate with
269other potentially mechanoresponsive molecules: b-cate-
270nin [21], focal adhesion kinase [22], and integrin aVb3
271[23,24]. Whether the mechanically induced behavior of
Fig. 4. HOS and 13 dyn/cm2 FSS lead to tyrosine phosphorylation of
PECAM-1 in REN-HP cells. Cell lysates were immunoprecipitated
with anti-PECAM-1 mAb 4G6 and membranes were blotted with anti-
PECAM-1 mAb 1.3 (upper panel), stripped and reprobed with anti-PY
pAb PY20 (lower panel).
Fig. 5. HOS and 13dyn/cm2 FSS induce tyrosine phosphorylation of
PECAM-1 in REN cells transfected with the K151/R152A mutant of
PECAM-1. Cell lysates were immunoprecipitated with anti-PECAM-1
mAb 4G6 and membranes were blotted with anti-PECAM-1 pAb PCD
(upper panel), stripped, and reprobed with anti-PY pAb PY20 (lower
panel).
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272 these molecules modulates or is modulated by PECAM-
273 1 has not been elucidated.
274 Mechanical stress is an important determinant of
275 endothelial cell behavior [1,2]. Areas of disturbed ﬂow,
276 for example, are more prone to atheroma formation
277 [25,26]. Abnormal mechanical stress may also play a
278 role in the pathogenesis of pulmonary hypertension
279 [27], ventilator-induced lung injury [28,29] or glomer-
280 ulonephropathy [30]. PECAM-1 is expressed abun-
281 dantly on endothelial cells, platelets, and most
282 leukocytes. It is believed to play a role in mediating
283 adhesion between adjacent endothelial cells, angiogen-
284 esis, and neutrophil adhesion to, and migration
285 through, the endothelial monolayer [9,31,32]. PECAM-
286 1-null mice, however, do not display developmental
287 abnormalities or signiﬁcant vascular defects, although
288 bleeding time is increased, leukocyte transendothelial
289 migration is slowed, and the blood–brain barrier may
290 be weakened [33–35].
291 In summary, utilizing EC-like REN cells stably
292 transfected with wild-type and mutant PECAM-1
293 constructs to elucidate which domains of PECAM-1
294 confer mechanosensitivity, we demonstrate that in the
295 conﬂuent monolayer, phosphorylation does not depend
296 upon lateral membrane localization of the protein and
297 cell–cell homophilic PECAM-1 binding. The trans-
298 membrane and extracellular domains of PECAM-1 are
299 not necessary for mechano-responsiveness. The kinase,
300 which remains to be identiﬁed, appears to be activated
301 by a more direct eﬀect of mechanical stress on the
302 cells.
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